vimarsana.com
Home
Live Updates
Lineage Announces Initiation of Development Activities for H
Lineage Announces Initiation of Development Activities for H
Lineage Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Eterna Therapeutics
Lineage Cell Therapeutics, Inc. ; class='js-l-obf link link--blue'
Related Keywords
United States ,
American ,
Matt Angel ,
Brianm Culley ,
Roche Group ,
Genentech ,
Eterna Therapeutics Inc ,
Factor Bioscience Inc ,
Exchange Commission ,
Lineage Cell Therapeutics Inc ,
Lineage Cell Therapeutics ,
Eterna Therapeutics ,
Chief Executive Officer ,
Cell Therapeutics ,
Factor Bioscience ,
Annual Report ,
Quarterly Report ,
Markets ,